BIOMAT Database Logo BIOMAT Database Logo

Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential. 1993

P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Department of Pharmacy, King's College London, U.K.

The synthesis of a range of novel bidentate ligands containing the chelating moiety 3-hydroxy-4(1H)-pyridinone is described. The pKa values of the ligands and the stability constants of their iron(III) complexes have been determined. The crystal structures of one of the ligands and one of the iron(III) complexes are presented. The distribution coefficients of the ligands are reported and are related to the ability of the ligands to remove iron from hepatocytes. The influence of 3-hydroxy-4(1H)-pyridinones on oxidative damage to cells is described. In contrast to the iron chelator in current therapeutic use, desferrioxamine-B, many of the bidentate ligands described in this study are orally active in iron-overloaded mice.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D007502 Iron Chelating Agents Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. Iron Chelates,Agents, Iron Chelating,Chelates, Iron,Chelating Agents, Iron
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D003461 Crystallography The branch of science that deals with the geometric description of crystals and their internal arrangement. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystallographies
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
August 1998, Journal of medicinal chemistry,
P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Design, synthesis and evaluation of N-basic substituted 3-hydroxypyridin-4-ones: orally active iron chelators with lysosomotrophic potential.
March 2000, The Journal of pharmacy and pharmacology,
P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Synthesis, chelating properties towards gallium and biological evaluation of two N-substituted 3-hydroxy-4-pyridinones.
March 2000, Journal of inorganic biochemistry,
P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential.
May 1999, The Journal of pharmacy and pharmacology,
P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics.
January 2004, Nucleosides, nucleotides & nucleic acids,
P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties, and biological activity.
June 1990, Journal of medicinal chemistry,
P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators.
March 2002, The Journal of pharmacy and pharmacology,
P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Development of an HPLC method for measuring orally administered 1-substituted 2-alkyl-3-hydroxypyrid-4-one iron chelators in biological fluids.
January 1990, Clinical chemistry,
P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Bifunctional 3-Hydroxy-4-Pyridinones as Potential Selective Iron(III) Chelators: Solution Studies and Comparison with Other Metals of Biological and Environmental Relevance.
November 2021, Molecules (Basel, Switzerland),
P S Dobbin, and R C Hider, and A D Hall, and P D Taylor, and P Sarpong, and J B Porter, and G Xiao, and D van der Helm
Design, synthesis, and biological evaluation of aromatic ester prodrugs of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) as orally active iron chelators.
May 2000, Arzneimittel-Forschung,
Copied contents to your clipboard!